Prevalence of carbapenem resistant pseudomonas aeruginosa and acinetobacter baumannii in high complexity hospital

Brazilian Journal of Infectious Diseases

Volumn 14, Issue 5, 2010, Pages 433-436

  Baumgart, Ana Milda Karsten ^a,c   Molinari, Marcelo André ^a,c   de Silveira, Alessandro Conrado Oliveira ^b,c  

^a Pharmaceutical Biochemistry Laboratório Santa Isabel Blumenau   (Brazil)

^b Microbiology and Clinical Immunology   (Brazil)

^c REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

Author keywords

Acinetobacter baumannii; Carbapenems; Drug resistance; Hospital infection control program; Pseudomonas aeruginosa

Indexed keywords

CARBAPENEM; IMIPENEM; MEROPENEM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; DRUG USE; HOSPITAL INFECTION; MORBIDITY; MORTALITY; NONHUMAN; PREVALENCE; PSEUDOMONAS AERUGINOSA; TREND STUDY;

EID: 78951488622     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702010000500002     Document Type: Article

References (23)

1. Ambler, RP. The structure of ß-lactamases. Phil. Trans. R Soc. Lond. B, London, v. 289, n. 1036, pp. 321-31, May 1980.
2. Andrade SS, Jones RN, Gales AC, Sader HS. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). J. Antimicrob. Chemother., London, v. 52, n. 1, pp.140-1, jul. 2003.
3. CLSI (Clinical and Laboratory Standards Institute). Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement - Table M100 - S18, Wayne, PA: NCCLS, 2009.
4. Donald HM, Scaife W, Amyes SG et al. Sequence analysis of ARI-1, a novel OXA ß-Lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob. Agents Chemother London, oct. 2003; 52(4):699-702.
5. Gales AC, Menezes LC, Silbert S et al. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-ß-lactamase. J. Antimicrob. Chemother., London, v. 52, n. 4, p. 699-702, oct. 2003.
6. Gales AC, Tognim MC, Reis AO et al. Emergence of an IMPlike metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn. Microbiol. Infect. Dis. New York, jan. 2003; 45(1):77-9.
7. Gales AC, Costa LD. Novos padrões de resistência: como incorporar a detecção no laboratório. Microbiologia in foco, São Paulo, 2009; 7:27-34.
8. Jin W, Arakawa Y, Yasuzawa H et al. Comparative study of the inhibition of metallo-ß-lactamases (IMP-1 and VIM-2) by thiol compounds that contain a hydrophobic group. Biol. Pharm. Bull, Tokyo jun. 2004; 27:851-6.
9. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J. Antimicrob. Chemother London, mar. 2001; 47(3):247-50.
10. Nordmann P, Poirel L. Emerging carbapenemases in gramnegative aerobes. Clin. Microbiol. Infect. Oxford jun. 2002; 8(6):321-31.
11. Nordmann P. Mécanismes de résistance aux bêtalactamines de Pseudomonas aeruginosa. Ann. Fr. Anesth. Reanim. Paris, jun.2003; 22(6):527-30.
12. Oliver A. Resistencia a carbapenemas y Acinetobacter baumannii. Enferm. Infecc. Microbiol. Clin., Barcelona may 2004; 22(5):259-61.
13. Picolli SU. Metalo-ß-lactamases e Pseudomonas aeruginosa. Rev. Bras. Anal. Clin., Rio de Janeiroout/dez. 2008; 40(4):273-7.
14. Poirel L; Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect., Oxfordsep. 2006; 12(9):826-36.
15. Quinteira S, Sousa JC, Peixe L. Characterization of In100, a new integron carrying a metallo-ß-lactamase and a carbenicillinase, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother., Washington jan. 2005; 49(1):451-3.
16. Sader HS, Jones RN, Gales AC et al. SENTRY Participants Group (Latin America). SENTRY antimicrobial surveillance program report: latin american and brazilian results for 1997 through 2001. Brazilian Journal of Infectious Diseases, Salvador 2004; 8(1):25-79.
17. Sader HS, Castanheira M, Mendes RE et al. Dissemination and diversity of metallo-ß-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int. J. Antimicrob. Agents, Amsterdamjan. 2005; 25(1):57-61.
18. Siegel, Sidney. Estatistica não-paramétrica para as ciências do comportamento. Porto Alegre: ArtMed, 2006.
19. StatSoft Inc. (2001). STATISTICA (data analysis software system), version 6. www.statsoft.com.
20. Tognim MC, Gales AC, Penteado AP, et al. Dissemination of IMP-1 metallo-ß-lactamase-producing Acinetobacter species in a Brazilian teaching hospital. Infect. Control Hosp. Epidemiol., New Jerseyjul. 2006; 27(7):742-7.
21. Toleman MA, Simm AM, Murphy TA et al. Molecular characterization of SPM-1 a novel metallo-ß-lactamase isolated in Latin America: report from the SENTRY Antimicrobial Surveillance Program. J. Antimicrob. Chemother., London, nov. 2002; 50(5):673-9.
22. Walther-Rasmussen, JW; Hoiby, N. Oxa-type carbapenemases. J. Antimicrob. Chemother. London, mar. 2006; 57(3):373-83.
23. Woodford N, Palepou MF, Babini GS, Holmes B, Livermore DM. Carbapenemases of Chryseobacterium (Flavobacterium) meningosepticum: distribution of blaB and characterization of a novel metallo-ß-lactamase gene, blaB3, inthe type strain, NCTC 10016. Antimicrob. Agents Chemother., Washington, jun. 2000; 44(6):1448-52.